Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Sun Pharma gets USFDA nod for pantropazole tablets
BackBack

Sun Pharma gets USFDA nod for pantropazole tablets

Sun Pharma gets USFDA nod for pantropazole tablets

Premium

PTI

New Delhi: Mumbai-based pharmaceutical firm Sun Pharma today said it has received final approval from the USFDA for the abbreviated new drug application (ANDA) of pantoprazole tablets, used for treating oesophagus ailments.

The approval for pantoprazole tablets, generic version of Wyeth’s Protonix, is for multiple strengths of 20mg and 40 mg, the company said in a statement.

“Sun Pharma being one of the first-to-file an ANDA for generic Protonix with a para IV certificate, shares a 180-day marketing exclusivity," it added.

“The company is currently evaluating its launch options," it added.

Annual sales of the two strengths of Protonix in the US is estimated at $2.3 billion.

Pantoprazole is indicated for short-term treatment of erosive oesophagitis and hypersecretory conditions.

The company’s stock was trading at Rs1,012, up 0.89% from the last close of Rs1,003.10.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 11 Sep 2007, 12:59 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App